Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0061 USD -0.01 ( 60.65%)
Last update at 2024-10-30T13:30:00Z
VOLUME
208509
Market Cap
5.61M

Momentum Score

…

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.13
Low
10.31
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
48.83M
Revenue Per Share
8.63
Gross Profit TTM
16.53M
Debt / Equity
-72.51
ROE
-504.76%
Net Debt
11.34M
ROCE
-164.13%
Diluted EPS TTM
-12.15

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -28.52M -16.09M -16.70M -17.90M -21.45M
Net income -28.63M -16.16M -16.83M -17.86M -21.52M
Selling general administrative 12.31M 11.26M 9.77M 10.75M 11.77M
Selling and marketing expenses 21.68M 15.34M 11.24M 14.40M 18.12M
Gross profit 15.91M 16.53M 6.17M 14.29M 16.89M
Reconciled depreciation 0.50M 0.40M 0.50M 0.98M 0.94M
Ebit -25.34M -16.12M -18.54M -15.62M -18.20M
Ebitda -24.84M -15.72M -13.82M -14.64M -17.25M
Depreciation and amortization 0.50M 0.40M 4.71M 0.98M 0.94M
Non operating income net other - - 4.19M -0.12M -0.06M
Operating income -25.34M -16.12M -18.54M -15.62M -20.89M
Other operating expenses 73.80M 55.30M 41.32M 53.42M 64.36M
Interest expense 2.75M 2.22M 2.36M 2.16M 0.51M
Tax provision 0.11M 0.07M 0.13M -0.04M 0.06M
Interest income - - - 2.28M 0.57M
Net interest income -2.75M -2.22M -2.36M -2.16M -0.51M
Extraordinary items - - - - 0.60M
Non recurring - - - - 1.50M
Income tax expense 0.11M 0.07M 0.13M -0.04M 0.06M
Total revenue 48.46M 39.19M 22.78M 37.80M 46.16M
Total operating expenses 41.25M 32.65M 24.71M 29.91M 35.09M
Cost of revenue 32.55M 22.66M 16.61M 23.51M 29.26M
Total other income expense net -3.19M 0.02M 1.83M -2.28M -2.74M
Net income from continuing ops -28.63M -16.16M -16.83M -17.86M -21.52M
Net income applicable to common shares - -16.70M -34.21M -17.86M -21.52M
Preferred stock and other adjustments - - 17.38M - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 35.10M 38.19M 55.28M 41.02M 31.85M
Other current assets 1.38M 3.05M 2.01M 3.02M 1.16M
Total liab 35.35M 33.30M 30.08M 31.00M 31.47M
Total stockholder equity -0.25M 4.89M 25.21M 10.03M 0.38M
Deferred long term liab - - - 0.37M 0.44M
Other current liab 7.99M 9.21M 7.87M 6.36M 4.74M
Common stock 0.00M 0.01M 0.15M 0.10M 0.03M
Capital stock 2.21M 0.01M 0.19M 0.22M 0.03M
Retained earnings -316.80M -296.17M -267.53M -251.38M -234.55M
Other liab - 1.14M 1.18M 1.81M 1.72M
Good will 2.93M 2.93M 2.93M 2.93M 2.93M
Other assets - 0.26M 0.22M 2.21M 0.43M
Cash 6.57M 4.18M 29.97M 17.56M 5.79M
Total current liabilities 19.66M 17.81M 13.84M 11.22M 25.78M
Current deferred revenue 2.45M 2.11M 2.26M 1.91M 2.24M
Net debt 11.34M 10.87M -14.92M 0.40M 7.68M
Short term debt 3.15M 0.70M 0.41M 0.30M 13.47M
Short long term debt 2.27M 0.70M - - 13.47M
Short long term debt total 17.91M 15.05M 15.05M 17.96M 13.47M
Other stockholder equity 314.90M 301.78M 293.18M 261.57M 231.63M
Property plant equipment - 6.05M 2.78M 2.76M 1.19M
Total current assets 24.86M 28.96M 49.35M 35.11M 27.02M
Net tangible assets - - 22.25M 6.98M 1.42M
Net receivables 5.48M 5.84M 4.24M 3.06M 8.76M
Long term debt 11.78M 13.09M 13.60M 16.19M -
Inventory 11.43M 15.88M 12.93M 11.16M 10.99M
Accounts payable 6.07M 5.79M 3.31M 2.65M 5.33M
Accumulated other comprehensive income -0.55M -0.73M -0.62M -0.39M -0.70M
Common stock total equity - - - 0.10M 0.03M
Preferred stock total equity - - - 0.12M -
Retained earnings total equity - - - -251.38M -234.55M
Non currrent assets other 0.27M 0.26M 0.22M 0.23M 0.43M
Non current assets total 10.24M 9.23M 5.93M 5.92M 4.83M
Capital lease obligations 1.66M 1.90M 1.85M 1.77M 0.32M
Long term debt total - - - 16.19M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.73M -0.71M -0.10M -0.21M -0.52M
Change to liabilities -0.06M 2.07M -2.49M -3.16M 1.76M
Total cashflows from investing activities - -0.71M -0.10M -0.21M -0.52M
Net borrowings -1.00M -1.00M 2.44M 2.37M 11.40M
Total cash from financing activities 4.60M 29.95M 24.35M 10.72M 11.23M
Change to operating activities -1.14M 0.28M 0.82M 0.44M -0.03M
Net income -28.63M -16.16M -16.83M -17.86M -21.52M
Change in cash -25.99M 12.30M 11.78M -2.25M -3.54M
Begin period cash flow 30.18M 17.88M 6.10M 8.36M 11.90M
End period cash flow 4.18M 30.18M 17.88M 6.10M 8.36M
Total cash from operating activities -26.76M -16.71M -12.79M -12.75M -14.15M
Issuance of capital stock 5.60M 14.42M 9.61M 9.17M 0.00M
Depreciation 0.50M 0.40M 0.50M 0.98M 0.94M
Other cashflows from investing activities - - - - 0.04M
Dividends paid -0.22M -0.55M -17.38M - -
Change to inventory -5.75M -1.38M -0.87M 0.84M -0.13M
Change to account receivables -1.64M -0.98M 4.29M 0.66M -1.46M
Sale purchase of stock - - 17.38M 9.18M -0.16M
Other cashflows from financing activities 0.22M 16.08M 21.14M 1.55M 14.98M
Change to netincome 5.25M -1.47M -0.36M 4.86M 6.10M
Capital expenditures 3.73M 0.71M 0.10M 0.21M 0.56M
Change receivables - - 4.29M 0.66M -1.46M
Cash flows other operating - - 1.83M 0.60M -0.18M
Exchange rate changes - - 0.32M -0.02M -0.11M
Cash and cash equivalents changes - - 11.78M -2.25M -3.54M
Change in working capital -5.07M 0.01M 1.75M -1.11M -0.01M
Stock based compensation 2.30M 1.66M 3.37M 2.74M 2.77M
Other non cash items 4.14M 0.99M 0.50M 2.49M 3.69M
Free cash flow -30.49M -17.42M -12.89M -12.95M -14.71M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIOL
BIOLASE Inc
-0.01
60.65%
0.01 - - 0.10 0.77 0.33 -1.04
ABT
Abbott Laboratories
-1.78
1.70%
103.10 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-0.84
0.89%
93.95 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-4.71
1.54%
301.42 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.55 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

BIOLASE Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

27042 Towne Centre Drive, Foothill Ranch, CA, United States, 92610-2811

949 361 1200

157

Name Title Year Born
Mr. John R. Beaver Pres, CEO & Director 1961
Ms. Jennifer Bright Chief Financial Officer 1971
Mr. Steven Sandor Chief Operating Officer 1980
Mr. Matthew Wilson VP of HR NA
Dr. Russell Morrow D.D.S. Chief Dental Officer NA
Mr. Michael C. Carroll Corp. Sec. 1972
Mr. David Rodriguez Director of Education & Events NA
Mr. John R. Beaver President, CEO & Director 1961
Ms. Jennifer Bright Chief Financial Officer 1972
Mr. Steven Sandor Chief Operating Officer 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…